301 related articles for article (PubMed ID: 28871426)
1. Assessment of overactive bladder symptoms among women with successful pessary placement.
Zacharakis D; Grigoriadis T; Pitsouni E; Kypriotis K; Vogiatzis N; Athanasiou S
Int Urogynecol J; 2018 Apr; 29(4):571-577. PubMed ID: 28871426
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).
Herschorn S; Chapple CR; Abrams P; Arlandis S; Mitcheson D; Lee KS; Ridder A; Stoelzel M; Paireddy A; van Maanen R; Robinson D
BJU Int; 2017 Oct; 120(4):562-575. PubMed ID: 28418102
[TBL] [Abstract][Full Text] [Related]
3. Pelvic organ prolapse and overactive bladder.
de Boer TA; Salvatore S; Cardozo L; Chapple C; Kelleher C; van Kerrebroeck P; Kirby MG; Koelbl H; Espuna-Pons M; Milsom I; Tubaro A; Wagg A; Vierhout ME
Neurourol Urodyn; 2010; 29(1):30-9. PubMed ID: 20025017
[TBL] [Abstract][Full Text] [Related]
4. A retrospective comparison of ring pessary and multicomponent behavioral therapy in managing overactive bladder.
Sze EH; Hobbs G
Int Urogynecol J; 2014 Nov; 25(11):1583-8. PubMed ID: 24803217
[TBL] [Abstract][Full Text] [Related]
5. Changes in Prolapse and Urinary Symptoms After Successful Fitting of a Ring Pessary With Support in Women With Advanced Pelvic Organ Prolapse: A Prospective Study.
Ding J; Chen C; Song XC; Zhang L; Deng M; Zhu L
Urology; 2016 Jan; 87():70-5. PubMed ID: 26375847
[TBL] [Abstract][Full Text] [Related]
6. Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary.
Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
Maturitas; 2018 Nov; 117():51-56. PubMed ID: 30314561
[TBL] [Abstract][Full Text] [Related]
7. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
[TBL] [Abstract][Full Text] [Related]
8. Management of Overactive Bladder in the Face of High Grade Prolapse.
Guzman-Negron J; Vasavada S
Curr Urol Rep; 2017 Feb; 18(2):12. PubMed ID: 28213857
[TBL] [Abstract][Full Text] [Related]
9. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
Dokmeci F; Cetinkaya SE; Seval MM; Dai O
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
Ginsberg D; Schneider T; Kelleher C; Van Kerrebroeck P; Swift S; Creanga D; Martire DL
BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with pessary fitting in women with symptomatic pelvic organ prolapse: A large prospective cohort study.
Ma C; Xu T; Kang J; Zhang Y; Ma Y; Liang S; Zhu L
Neurourol Urodyn; 2020 Nov; 39(8):2238-2245. PubMed ID: 32936968
[TBL] [Abstract][Full Text] [Related]
12. [The influence of mesh pelvic floor reconstructive surgery on OAB symptoms].
Nowakowski L; Wróbel A; Jankiewicz K; Kulik-Rechberger B; Rechberger T
Ginekol Pol; 2014 Oct; 85(10):760-4. PubMed ID: 25546927
[TBL] [Abstract][Full Text] [Related]
13. [Non-neurological overactive bladder and pelvic-perineal pathology in women].
Gamé X; Phé V
Prog Urol; 2020 Nov; 30(14):887-894. PubMed ID: 33220817
[TBL] [Abstract][Full Text] [Related]
14. How does site of pelvic organ prolapse repair affect overactive bladder symptoms?
Dieter AA; Edenfield AL; Weidner AC; Siddiqui NY
Female Pelvic Med Reconstr Surg; 2014; 20(4):203-7. PubMed ID: 24978085
[TBL] [Abstract][Full Text] [Related]
15. One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires.
Lone F; Thakar R; Sultan AH
Int Urogynecol J; 2015 Sep; 26(9):1305-12. PubMed ID: 25862241
[TBL] [Abstract][Full Text] [Related]
16. Natural history of lower urinary tract symptoms in treatment-seeking women with pelvic organ prolapse; the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN).
Kowalski JT; Wiseman JB; Smith AR; Helmuth ME; Cameron A; DeLancey JOL; Hendrickson WK; Jelovsek JE; Kirby A; Kreder K; Lai HH; Mueller M; Siddiqui N; Bradley CS
Am J Obstet Gynecol; 2022 Dec; 227(6):875.e1-875.e12. PubMed ID: 35934118
[TBL] [Abstract][Full Text] [Related]
17. Potential Primary Endpoint for Exploratory Clinical Trial in Patients with Overactive Bladder: A Systematic Literature Review.
Iino S; Kaneko M; Narukawa M
Low Urin Tract Symptoms; 2018 Jan; 10(1):64-75. PubMed ID: 27792298
[TBL] [Abstract][Full Text] [Related]
18. Impact on quality of life after ring pessary use for pelvic organ prolapse.
Manchana T; Bunyavejchevin S
Int Urogynecol J; 2012 Jul; 23(7):873-7. PubMed ID: 22222673
[TBL] [Abstract][Full Text] [Related]
19. Can botox improve night-time overactive bladder symptoms in women?
Miotla P; Cartwright R; Futyma K; Bogusiewicz M; Skorupska K; Winkler I; Rechberger T
Neurourol Urodyn; 2017 Mar; 36(3):648-652. PubMed ID: 26915654
[TBL] [Abstract][Full Text] [Related]
20. A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.
Herschorn S; Barkin J; Castro-Diaz D; Frankel JM; Espuna-Pons M; Gousse AE; Stölzel M; Martin N; Gunther A; Van Kerrebroeck P
Urology; 2013 Aug; 82(2):313-20. PubMed ID: 23769122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
